New research suggests that individuals who discontinue blockbuster slimming jabs like Mounjaro or Wegovy can put back on shed pounds much more quickly than those who stop conventional diet and exercise regimens.
Published data in a major health publication points out that while overweight individuals frequently drop a large proportion of their total mass while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month after stopping.
"Users using such treatments must be aware of the danger of quick rebound weight gain when the treatment ends," stated expert Dr. Susan Jebb.
This pace of recovery implies a return to starting weight in about one and a half years.
Analyzing Therapies
The study, which examined 37 of trials involving over 9,000 of patients, contrasted the effects of the injectable medications with conventional dieting.
Scientists emphasize that individuals who shed pounds through lifestyle changes alone typically experience a less rapid creep back—approximately 100 grams monthly—after stopping.
The Reason for the Rapid Rebound
Doctors suggest the mechanism of the jabs explains the accelerated weight return.
These medications copy a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Long-term administration of the hormone concentrations several times higher than normal might result in the system to produce less of its own natural GLP-1, and could reduce responsiveness to its actions," said Dr. Adam Collins, a nutrition specialist.
"Discontinuation of this medication leads to hunger is no longer kept in check, making excessive eating much more probable."
A Lifelong Disease?
The NHS recommend the jabs for people with weight-linked health risks, accompanied by recommended lifestyle changes.
Many experts argue that, given the likelihood of weight regain, the therapy is often long-term.
This perspective is reinforced by pharmaceutical companies, who state that the findings "emphasize the long-term character of obesity," akin to managing diseases like diabetes.
Patient Experiences
Individuals who have discontinued the jabs report a powerful resurgence of hunger.
"It felt as if something flipping and I was suddenly ravenous," recalled one woman.
This difficulty is compounded if users have not developed lasting lifestyle or habit changes during treatment.
Significant Interest
Figures indicate that a significant number of people in the UK have used these injections in the past year, with desire remaining high.
- Adoption is higher among women compared to men.
- The middle-aged demographic shows the greatest usage rates.
- A large proportion obtain the drugs through private prescriptions rather than public health services.
Ultimately, experts stress that while GLP-1 drugs are effective tools for shedding pounds, they are not a standalone cure and long-term success likely depends on combined behavioural management.